Filing Manager
Adimab, LLC
Reporting Manager
Adimab, LLC
Symbol
IVVD
Shares outstanding
277,563,973 shares
Disclosed Ownership
20,262,170 shares
Ownership
7.3%
Form type
SCHEDULE 13D/A
Filing time
29 Dec 2025, 16:15:02 UTC
Date of event
23 Dec 2025
Previous filing
19 Nov 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adimab, LLC 7.3% 20,262,170 20,262,170 /s/ Philip Chase Philip Chase, Chief Executive Officer 0001545672